Atopix Therapeutics is a clinical-stage biopharmaceutical company focused on developing innovative treatments for atopic diseases, including eczema and asthma. The company utilizes its proprietary science to create therapies designed to address the underlying causes of these conditions, aiming to improve the quality of life for patients.